Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
USFDA Archives - Page 3 of 5 - The Pharma Times | Pharma & Health Care News Portal

USFDA

Dr. Reddy’s Laboratories launches Tadalafil Tablets USP in the U.S. Market

New Delhi, February 05, 2019: Dr. Reddy’s Laboratories Ltd. ((BSE: 500124, NSE: DRREDDY, NYSE: RDY), along with its subsidiaries together…

5 years ago

World’s First Smart Continuous Glucose Monitoring System now in India

Eris Lifesciences joins hands with Medtronicto bring Guardian Connect to India Mumbai, January 04, 2019 : Guardian Connect is the world’s first…

5 years ago

Morepen Labs begins FY 2018-19 with a Sound Performance in the First Quarter

Company reports 93 percent rise in its consolidated net profit and 26 percent rise in its consolidated net sales revenue…

6 years ago

Twin USFDA Approvals for Morepen Labs’ Bulk Drugs (API) Facilities

Baddi facility gets US FDA nod for bulk drug “Atorvastatin” and Masulkhana facility for “Montelukast” New Delhi, August 05, 2018:…

6 years ago

Aurobindo gets USFDA nod for antibiotic

Mumbai, August 04, 2018: Aurobindo Pharma said on 5 June it has received approval from the US Food and Drug…

6 years ago

Dr Reddy’s launches Plaquenil’s generic version in US after USFDA clearance

New Delhi, August 04, 2018: Dr Reddy’s Laboratories on Wednesday announced the launch of generic version of Plaquenil, used to…

6 years ago

WuXi STA’s Jinshan Site Passes Fourth U.S. FDA Inspection

Shanghai, July 29, 2018: STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, announces that its Active Pharmaceutical Ingredient (API)…

6 years ago

Biologics, research boost Biocon profit

Firm’s net rises 47% for June quarter New Delhi, July 26, 2018: India’s largest biopharmaceutical firm Biocon announced that consolidated…

6 years ago

Near 8-fold jump in Dr Reddy’s Q1 profit

Hyderabad, July 26, 2018: Pharma major Dr Reddy’s Laboratories’ consolidated net profit increased to ₹456 crore in the first quarter ended…

6 years ago

Strides Shasun receives USFDA Tentative Approval for Milnacipran Hydrochloride Tablets

Product approval under the para IV route  Bangalore, July 04, 2018: Strides Shasun Limited today announced that its wholly owned…

6 years ago